Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
about
Cancer stem cells: a metastasizing menace!Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsNanomedicine-Mediated Therapies to Target Breast Cancer Stem CellsMetabolic control of cancer cell stemness: Lessons from iPS cellsAldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical applicationAldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcomaChemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cellsHead and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde DehydrogenaseSoluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cellsRaf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cellsiRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases.Oral epithelial stem cells - implications in normal development and cancer metastasis.Circulating tumor cells: from bench to bedsideThe novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity.High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells.Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsMultiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review).Oxidative stress and its significant roles in neurodegenerative diseases and cancer.Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.Cancer stem cells as a target population for drug discovery.Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30.The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.Different Biological Action of Oleic Acid in ALDHhigh and ALDHlow Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer.Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer.High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.Cancer stem cells and chemoresistance: The smartest survives the raidStem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin.Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.CD44(+) gastric cancer cells with stemness properties are chemoradioresistant and highly invasive.Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling.Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells.A triple negative breast cancer: what it is not!Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity
P2860
Q26771651-AE7F5800-6263-4F04-B61E-088C15C1B0F6Q26786476-15CAD79C-B731-4F61-B357-FE5EB6EBF5E1Q28066297-9CD6A298-682B-435C-8DA8-45B5BA7EEE2BQ28081608-B9FEB04D-8012-4EFC-AA39-42BF500CD42EQ28265682-5FEC4274-5285-4208-8E35-2697814BB11DQ28482489-F7577EAE-98D9-4B27-856C-EF489B3C6A62Q28484299-AB8BCCF4-A1AB-4C63-B591-C4EFF98EC480Q33636562-83678905-B5B7-4134-A499-8FC0F3C395B4Q33675150-840429A8-6BAD-4EBC-B703-D70B84B0E51EQ33759701-35BE56BB-84A8-469D-9760-4F92CBBAE7AAQ33766557-86AC3087-8DB3-4BD6-A568-AA57D818B9D7Q33778101-CC02224F-27EE-4F57-8732-6C9ADEC1EC27Q33985495-768D4C18-9523-4F6E-92AC-B6AD5517152CQ34147649-6C05A9B2-9ED5-4016-B939-3C6375E0A8FEQ34307782-31DD4F69-50A4-4945-AB2F-3A39F655A521Q34449025-EB6C4B52-EF2F-4AE3-B5F2-DEF975B87E49Q34481639-BAC67B08-1623-4648-B6F3-E6F7E61215DBQ34483548-5A9FD2C1-761D-4FD0-BE96-E4B72BD2BA5EQ34786571-AE185111-935D-46E2-8480-8FB68A7528B0Q34795591-2B49D784-86B2-410E-BDD4-4D9451A7A3EFQ35016411-953777D9-A744-43DD-9C07-9F2F1B3DE749Q35177969-7BBEB9D5-282B-4F23-B2CA-19B7135864CEQ35390334-88273902-2001-4F81-A3C6-EA1AAB03B92CQ35550185-6C8675CE-D2E5-4B85-AD66-011D151BF4A4Q35826507-2022DA11-9663-4D6A-B167-FDB4D3E1BB9EQ35960211-08EB0AD2-E192-4464-8B52-DB44FC01E9C8Q36088183-B5956E79-F5C1-4E15-B816-F9C6FD791C7EQ36121716-B64B2C19-9FDF-4999-9D78-81BC645103FBQ36279794-0F5C9A48-438E-454C-A725-A3B6345ADF68Q36544355-7D05ACB4-5DCD-4EC2-8876-B319B4D2E076Q36544839-9709E088-8F11-47B3-B46D-21370F0C7FCDQ36670686-6E42A91A-05A0-40C5-9874-90B60B53CD72Q36730432-C858CE0A-C4F6-4F1E-94E4-5009C50C4775Q36802896-619B3F5A-F241-45A1-BDE8-AFB65C938A44Q36958447-357ADC31-929B-445D-9D01-A8FCBB5CFFFCQ36981362-DE166A79-562A-4D56-B395-28A3BEAD73C0Q37190831-FC2D2151-611B-4B98-8F92-C0106CE53BF4Q37323067-F8C8551B-5115-4619-AF2F-6CFEDA759376Q37355581-438BA181-C2D5-4059-A2BC-F221B18DC519Q37372279-97473531-1B07-4D2F-B7BE-22730DF9D32E
P2860
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Inhibition of aldehyde dehydro ...... 44⁺ human breast cancer cells.
@en
Inhibition of aldehyde dehydrogenase
@nl
type
label
Inhibition of aldehyde dehydro ...... 44⁺ human breast cancer cells.
@en
Inhibition of aldehyde dehydrogenase
@nl
prefLabel
Inhibition of aldehyde dehydro ...... 44⁺ human breast cancer cells.
@en
Inhibition of aldehyde dehydrogenase
@nl
P2860
P1476
Inhibition of aldehyde dehydro ...... 44⁺ human breast cancer cells.
@en
P2093
Alison L Allan
P2860
P2888
P356
10.1007/S10549-011-1692-Y
P407
P577
2011-08-05T00:00:00Z